leisure time -WSS

leisure time

author：explore 2025-09-06 05:40:54 - browse：35272

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Roche acquires Telavant from Roivant, adding experimental IBD treatment

explore

WSS

UnitedHealth, Optum discontinue NaviHealth name

As obesity drug market grows, telehealth companies court payers

Abortion policy in the spotlight at Republican debate

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Readout LOUD podcast: Live from the 2023 STAT Summit

PBMs are inflating the cost of generic drugs. They must be reined in

entertainment

leisure time

explore

The high cost of giving birth even with insurance

STAT Summit: How researchers deal with rejection

Malaria cases in Florida and Texas: Here’s what you need to know

CDC says it’s too soon to assess risk posed by Covid subvariant

New air purifier tech could be key to improving indoor air quality

STAT Summit: How researchers deal with rejection

Guidelines to prevent youth baseball injuries need more muscle

Readout LOUD podcast: Live from the 2023 STAT Summit

Trump demands the U.S. pay no more for drugs than other countries … again

Study: Spinal cord stimulation helps patients with paralysis walk again

explore

Vivek Ramaswamy made waves in the debate, much as in biotech

STAT Summit: How researchers deal with rejection

Can U.S. cancer drug shortages be fixed?

Results on Novartis prostate cancer therapy could expand its use

How AI can help patients find reliable information about doctors

Questions loom on AstraZeneca cancer drug as safety concerns ebb

focus

explore

focus

hotspot